NCT06602843View on ClinicalTrials.gov

Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
PROCEDURE

Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy

Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy

Trial Locations (1)

Unknown

RECRUITING

Anhui provincial hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV